Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000930413-07-000196
Filing Date
2007-01-10
Accepted
2007-01-10 16:40:00
Documents
2
Period of Report
2007-01-08

Document Format Files

Seq Description Document Type Size
1 c46117_ex.html 3  
1 c46117_ex.xml 3 2149
2 c46117_ex24.txt EX-24 3150
  Complete submission text file 0000930413-07-000196.txt   7160
Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Issuer) CIK: 0000816284 (see all company filings)

EIN.: 222711928 | State of Incorp.: DE | Fiscal Year End: 0501
SIC: 2834 Pharmaceutical Preparations

Mailing Address DORSEY & WHITNEY LLP 250 PARK AVE NEW YORK NY 10177
Business Address ALFACELL CORP 225 BELLEVILLE AVE BLOOMFIELD NJ 07003 2127350775
LOUGHLIN JAMES J (Reporting) CIK: 0001276550 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-16132 | Film No.: 07523625